Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib Rechallenge in Metastatic pNET
NCT02713763Phase 2Completed
- Sponsor
- Spanish Group of Neuroendocrine Tumors
- Start
- Feb 2017
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in Pancreatic neuroendocrine tumor (PanNET), sponsored by Spanish Group of Neuroendocrine Tumors. Started Feb 2017; status: completed.
02
Drugs
sunitinib
03
Conditions
Pancreatic neuroendocrine tumor (PanNET)
Beyond the preview
Go deeper on NCT02713763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02713763.